Clear All
11888 Matching Results — Export these results
Click column titles once to sort ascending, and twice to sort descending.
NDC-11 (Package) NDC-9 (Product) Generic Name Brand Name Strength SEER*Rx Category Major Class Minor Class Administration Route Package Effective Date Package Discontinuation Date Status
00143-9167-01 00143-9167 Eribulin mesylate ERIBULIN MESYLATE 0.5 mg/mL Chemotherapy Antimitotic Agent Furopyrans Intravenous Jun 28, 2024 In Use
68083-0592-01 68083-0592 Eribulin mesylate Eribulin mesylate 0.5 mg/mL Chemotherapy Antimitotic Agent Furopyrans Intravenous Apr 5, 2024 In Use
66993-0489-35 66993-0489 Dactinomycin Dactinomycin 0.5 mg/mL Chemotherapy Antitumor Antibiotic Carboxylic Acids and Amino Acids/Peptides Intravenous Dec 4, 2017 Nov 30, 2024 No Longer Used
67457-0928-02 67457-0928 Dactinomycin Dactinomycin 0.5 mg/mL Chemotherapy Antitumor Antibiotic Carboxylic Acids and Amino Acids/Peptides Intravenous Jun 20, 2019 In Use
10019-0080-01 10019-0080 Eribulin Mesylate Eribulin Mesylate 0.5 mg/mL Chemotherapy Antimitotic Agent Furopyrans Intravenous Dec 1, 2024 In Use
71731-4171-01 71731-4171 Eribulin Mesylate Eribulin Mesylate 0.5 mg/mL Chemotherapy Antimitotic Agent Furopyrans Intravenous Mar 4, 2025 In Use
39822-2100-02 39822-2100 dactinomycin dactinomycin 0.5 mg/mL Chemotherapy Antitumor Antibiotic Carboxylic Acids and Amino Acids/Peptides Intravenous Jul 31, 2019 In Use
60505-6435-00 60505-6435 Eribulin mesylate Eribulin mesylate 0.5 mg/mL Chemotherapy Antimitotic Agent Furopyrans Intravenous Mar 19, 2025 In Use
68462-0770-20 68462-0770 Eribulin mesylate ERIBULIN MESYLATE 0.5 mg/mL Chemotherapy Antimitotic Agent Furopyrans Intravenous Aug 5, 2025 In Use
67457-0513-05 67457-0513 Dactinomycin Dactinomycin 0.5 mg/mL Chemotherapy Antitumor Antibiotic Carboxylic Acids and Amino Acids/Peptides Intravenous Jan 1, 2018 In Use
00781-3391-94 00781-3391 Eribulin Mesylate Eribulin Mesylate 0.5 mg/mL Chemotherapy Antimitotic Agent Furopyrans Intravenous Jul 7, 2025 In Use
70095-0080-01 70095-0080 ERIBULIN MESYLATE ERIBULIN MESYLATE 0.5 mg/mL Chemotherapy Antimitotic Agent Furopyrans Intravenous May 15, 2025 In Use
68001-0656-41 68001-0656 Eribulin Mesylate Eribulin Mesylate 0.5 mg/mL Chemotherapy Antimitotic Agent Furopyrans Intravenous Sep 15, 2025 In Use
71288-0129-02 71288-0129 Dactinomycin Dactinomycin 0.5 mg/mL Chemotherapy Antitumor Antibiotic Carboxylic Acids and Amino Acids/Peptides Intravenous Nov 13, 2020 In Use
40033-0364-01 40033-0364 Eribulin mesylate ERIBULIN MESYLATE 0.5 mg/mL Chemotherapy Antimitotic Agent Furopyrans Intravenous Aug 5, 2025 In Use
00046-1102-51 00046-1102 Estrogens, Conjugated Premarin 0.625 mg/1 Hormonal Therapy Estrogen Oral Jan 1, 2006 May 22, 2020 In Use
43353-0688-60 43353-0688 conjugated estrogens Premarin 0.625 mg/1 Hormonal Therapy Estrogen Oral Jan 1, 2006 In Use
55154-0216-00 55154-0216 conjugated estrogens Premarin 0.625 mg/1 Hormonal Therapy Estrogen Oral Jan 1, 2006 Oct 31, 2013 No Longer Used
54868-0451-00 54868-0451 conjugated estrogens Premarin 0.625 mg/1 Hormonal Therapy Estrogen Oral Feb 8, 2005 May 12, 2014 In Use
55154-0216-04 55154-0216 conjugated estrogens Premarin 0.625 mg/1 Hormonal Therapy Estrogen Oral Jan 1, 2006 Oct 31, 2013 No Longer Used
53808-0770-01 53808-0770 conjugated estrogens Premarin 0.625 mg/1 Hormonal Therapy Estrogen Oral Jul 1, 2009 In Use
50090-0167-00 50090-0167 Estrogens, Conjugated Premarin 0.625 mg/1 Hormonal Therapy Estrogen Oral Oct 29, 2018 In Use
00046-1102-52 00046-1102 Estrogens, Conjugated Premarin 0.625 mg/1 Hormonal Therapy Estrogen Oral Feb 10, 2020 In Use
69189-0078-01 69189-0078 esterified estrogens Menest 0.625 mg/1 Hormonal Therapy Estrogen Oral Nov 23, 2015 May 24, 2017 No Longer Used
49999-0109-00 49999-0109 conjugated estrogens Premarin 0.625 mg/1 Hormonal Therapy Estrogen Oral Mar 21, 2012 Jan 1, 2013 In Use

Found 11888 results — Export these results